Tag: #Global Trends

Terremoto Biosciences has successfully closed a $108 million Series C financing round. The capital will be utilized to push its... Read more

Swiss drugmaker Roche has announced plans to initiate a new global Phase 3 clinical trial for Elevidys. This move is... Read more

On April 16, President Trump tapped Erica Schwartz to lead the Centers for Disease Control and Prevention (CDC). If confirmed... Read more

On April 16, Kailera Therapeutics, an obesity drug developer, announced it had raised $625 million in its initial public offering... Read more

Following the recent approval of Foundayo (orforglipron), the U.S. Food and Drug Administration (FDA) is mandating a series of post-approval... Read more

The Swiss pharmaceutical giant Roche has announced the launch of a new global Phase 3 clinical trial for Elevidys. This... Read more

The U.S. Food and Drug Administration (FDA) has recently announced separate recalls initiated by Viatris and Teva Pharmaceutical Industries. Both... Read more

Johnson & Johnson reported first-quarter 2026 financial results that exceeded Wall Street’s expectations, driven by its innovative medicine division which... Read more

Regeneron Pharmaceuticals and Telix Pharmaceuticals have officially entered a strategic collaboration to advance next-generation radiopharmaceutical therapies. This partnership marks Regeneron’s... Read more